We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Unique Low-Cost, Non-Electric Ventilator Could Help Hospitals Treat COVID-19 Patients

By HospiMedica International staff writers
Posted on 05 Mar 2021
A new low-cost ventilator which does not require electricity could help hospitals treat COVID patients.

A team of engineers from Loughborough University (Loughborough, UK) has designed and built the unique low-cost, non-electric ventilator in response to the COVID-19 pandemic. More...
The ShiVent system was created to allow non-specialized workers to treat patients with coronavirus.

The system works by connecting hospital patients to an existing oxygen source and blends air with the high-flow oxygen supply. The patient inhales oxygen to fill up the lungs and then exhales into a water column creating back end pressure that keeps their airway open. It is based on the principles of bubble continuous positive airway pressure (CPAP) - a non-invasive ventilator used for new-born babies.

Simple to use by the average health workers, the ShiVent system takes only 30 minutes of training and can be produced at a very small fraction of the price of the average ventilator. Its non-electric operation makes it suitable for hospital settings with unreliable power. The ShiVent system is also oxygen-efficient as it requires almost as little as a third of the average oxygen consumption of high flow oxygen systems.

“ShiVent is designed for under-resourced areas where mechanical ventilators are scarce and expensive, with unreliable electricity supply and limited specialist knowledge,” said Yusuf Bilesanmi, a PhD student of Architecture Building and Civil Engineering, who is the founder and team leader. “The ShiVent is a simple, low-cost ventilatory alternative which does not depend on electricity and is widely replicable.”

Related Links:
Loughborough University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.